News

Business Wire3y
GC Pharma Announces EMA Grants Orphan Drug Designation to Hunterase ICV, The World’s First Enzyme Replacement Therapy for Mucopolysaccharidosis Type II ... - Business Wire
GC Pharma (006280.KS) today announced that the European Medicines Agency (EMA) granted orphan drug designation (ODD) to Hunterase ICV (intracerebroven ...
Business Wire3y
GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A - Business Wire
GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa) [Recombinant Human Coagulation Factor VIII for injection] for the ...
Yahoo Finance1mon
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California - Yahoo Finance
GC Biopharma, a South Korean pharmaceutical company, announced that its U.S. subsidiary, ABO Holdings, has received FDA approval for its plasma collection center located in Calexico, California.